Yale Cancer Center shared a post on LinkedIn:
“The 48th annual San Antonio Breast Cancer Symposium (SABCS), the world’s largest breast cancer conference, just concluded, and more than 20 faculty and trainees from Smilow Cancer Hospital and Yale Cancer Center were on-site to share updates and research advances.
Of our presentations, Eric Winer, MD, FASCO, was a discussant on a trial discussing treatment decisions for patients with DCIS, emphasizing that treatment for ductal carcinoma in situ (DCIS) should be based on thorough patient education and patient-centered decision making.
During an educational session moderated by Tara Sanft, MD, Maryam Lustberg, MD, MPH, highlighted the considerable unmet needs in menopause care for breast cancer survivors and those at high-risk, stressing that many symptoms experienced by patients remain overlooked. Dr. Lustberg also presented during a Quick Pitch session on why patient-reported outcomes must be central to oncology drug development and clinical trials.
Lajos Pusztai, MD, DPhil, shared research on how RNA levels of key genes (ESR1 and PGR) closely match traditional estrogen receptor/progesterone receptor test results in breast cancer, while Guannan Gong, PhD, shared how an AI-driven patient-matching system improved ID of eligible patients for breast cancer trials, increasing representation of under-enrolled groups. Attendees from Yale participated in formal lectures in clinical, translational, and basic research, selected slide and poster presentations, forums, and case discussions.
We are excited for our faculty and trainees who had the opportunity to share their groundbreaking research here at SABCS, but also at last week’s American Society of Hematology (ASH) Annual Meeting. We’re proud to be part of an institution that fosters creative and impactful research and clinical studies that make a difference.
Read our full recap.”
More posts featuring Yale Cancer Center.
